CLINICAL_TRIALS
trial_result
· 2016-01-21
Clinical Trial Update: A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients [Phase 4]
Summary
Phase 4 clinical trial update evaluating quetiapine extended-release (Seroquel SR) for SSRI-resistant panic disorder. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Panic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-01-21